Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evolocumab for Coronary Endothelial Function in HIV
NCT03500302Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- May 2018
- Primary completion
- Nov 2019
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of evolocumab in coronary artery disease (CAD), sponsored by Johns Hopkins University. Started May 2018; status: completed.
02
Drugs
evolocumab
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT03500302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03500302.